Diazepam-Binding Inhibitor: A Brain Neuropeptide Present in Human Spinal Fluid: Studies in Depression, Schizophrenia, and Alzheimer's Disease

Maria L. Barbaccia, Erminio Costa, Patrizia Ferrero, Alessandro Guidotti, Alec Roy, Trey Sunderland, David Pickar, Steven M. Paul, Frederick K. Goodwin

Research output: Contribution to journalArticlepeer-review

Abstract

Diazepam-binding inhibitor is a novel peptide purified to homogeneity from rat and human brain. Diazepam-binding inhibitor is present, though not exclusively, in γ-aminobutyric acid (GABA)—containing neurons where it is believed to inhibit GABAergic neurotransmission mediated by GABA by binding to the benzodiazepine-GABA receptor complex. Since an impairment of central GABAergic tone has been postulated to be associated with a number of neuropsychiatric disorders, we measured human diazepam-binding inhibitor immunoreactivity in the cerebrospinal fluid (CSF) of patients suffering from endogenous depression, schizophrenia, and dementia of the Alzheimer's type. Patients with major depression had significantly higher concentrations of human diazepam-binding inhibitor immunoreactivity in CSF when compared with age- and sex-matched normal volunteers, while no difference in CSF diazepam-binding inhibitor immunoreactivity was found in schizophrenics or patients with dementia of the Alzheimer's type when compared with controls. The possibility is discussed that the increased CSF human diazepam-binding inhibitor immunoreactivity observed in depressed patients may represent a functional disinhibition of GABAergic neurotransmission associated with depression.

Original languageEnglish (US)
Pages (from-to)1143-1147
Number of pages5
JournalArchives of General Psychiatry
Volume43
Issue number12
DOIs
StatePublished - 1986
Externally publishedYes

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Diazepam-Binding Inhibitor: A Brain Neuropeptide Present in Human Spinal Fluid: Studies in Depression, Schizophrenia, and Alzheimer's Disease'. Together they form a unique fingerprint.

Cite this